%20(1).png)
Our Partners
Our Partners
We are proud to develop and study our solutions with leading researchers, teams, and medical centers spanning the US, Europe, Africa, and beyond.
​
Kenya | Nigeria | Rwanda | Ethiopia | El Salvador | India | Los Angeles | Boston
Live Trials
OPTICs Trial
El Salvador ​
The most important AI trial in cervical cancer screening. A 10,000-patient study evaluating our complete platform in real-world screening and triage scenarios.
​
10,000 Patients
Across 42 clinics
​
$2M
This project is supported by the National Institutes of Health (NIH) under Small Business Innovation Research (SBIR) Grant. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. ​​View trial registration here.
​
4,000+ Enrolled
to date
The Live Quality Trial
Kenya​
The first live, guided trial for cervical cance screening led by nurses. A 360-patient study evaluating our CerVisibility AI in real-world screening and triage scenarios.​
​
360 Patients
Across 3 clinics
​
165 Enrolled
to date
Remote Diagnosis
India - Ministry of Health, Odisha​
The first live trial for cervical cancer screening, where nurses capture high quality images using CerVisibility. Remote experts review exam and send back results all through tablets.
​
500 Patients
Across 3 clinics
​
Planned Start: March 2026
Planned 2026 Trials​​
-
Malawi - retrospective colposcopic image analysis
-
Nigeria - Federal Medical Centers
-
Nigeria - CINFinder in a live clinical setting
-
Rwanda - Quality validation with nurses, treatment recommendations
-
Ethiopia - Quality validation with nurses
-
Kenya - Cost effectiveness study
-
CINFinder partners - retrospective analysis on cross-device images (bring CINFinder to expert devices)